![Max Rosett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Max Rosett
Finanzdirektor/CFO bei
IMMUNOME, INC.
Vermögen: 2 Mio $ am 30.09.2026
Profil
Max Rosett currently works at Immunome, Inc. as CFO, Chief Accounting Officer & EVP-Operations since 2024.
Formerly, Mr. Rosett was Chief Operating Officer at MorphImmune, Inc. from 2022 to 2023 and Principal at Research Bridge Partners from 2021 to 2023.
Mr. Rosett completed graduate education at Georgia Institute of Technology in 2016 and undergraduate education at Yale University in 2012.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMMUNOME, INC. 0.09% | 23.07.2026 | 101’287 ( 0.09% ) | 2 Mio $ | 30.09.2026 |
Aktive Positionen von Max Rosett
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNOME, INC. | Finanzdirektor/CFO | 02.01.2024 |
Ehemalige bekannte Positionen von Max Rosett
| Unternehmen | Position | Ende |
|---|---|---|
Research Bridge Partners /Venture Capital/
 Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners invests in companies located in the United States. The firm focuses on a biomedical sector. It provides finance for seed stage capital requirements. | Corporate Officer/Principal | 01.11.2023 |
MorphImmune, Inc.
 MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Geschäftsführer | 01.10.2023 |
Ausbildung von Max Rosett
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
85
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Immunome, Inc.
 Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Georgia Institute of Technology
 Georgia Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Research Bridge Partners /Venture Capital/
Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners invests in companies located in the United States. The firm focuses on a biomedical sector. It provides finance for seed stage capital requirements. | Finance |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Health Technology |
